\pub
{DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms}
{M Cannon, J Steveonson, K Stahl, R Basu, ..., {\bf AH Wagner}}
{Nucleic Acids Research}
{2024}

\pub
{Normalization of drug and therapeutic concepts with Thera-Py}
{M Cannon, J Stevenson, K Kuzma, S Kiwala, JL Warner, ..., {\bf AH Wagner}}
{JAMIA Open}
{2023}

\pub
{Sync for Genes Phase 5: Computable artifacts for sharing dynamically annotated FHIR‐formatted genomic variants}
{R Dolin, B Heale, ..., {\bf AH Wagner}, Srikar Chamala}
{Learning Health Systems}
{2023}

\pub
{Phenopacket-tools: Building and validating GA4GH Phenopackets}
{D Danis, JOB Jacobsen, {\bf AH Wagner}, T Groza, ..., PN Robinson}
{PloS one}
{2023}

\pub
{GA4GH Phenopackets: A Practical Introduction}
{MS Ladewig, JOB Jacobsen, {\bf AH Wagner}, D Danis, ..., PN Robinson}
{Advanced Genetics}
{2023}

\pub
{CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase}
{K Krysiak, ..., {\bf AH Wagner}, M Griffith, OL Griffith}
{Nucleic Acids Research}
{2023}

\pub
{Accessing clinical-grade genomic classification data through the ClinGen Data Platform}
{KP Dalton, ..., {\bf AH Wagner}}
{Pacific Symposium on Biocomputing}
{2022}

\pub
{Development and application of a computable genotype model in the GA4GH Variation Representation Specification}
{W Goar, ..., {\bf AH Wagner}}
{Pacific Symposium on Biocomputing}
{2022}

\pub
{Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine}
{Y Zhao, M Brush, C Wang,  {\bf AH Wagner}, H Liu, RR Freimuth}
{Bioinformatics}
{2022}

\pub
{Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing}
{O Neumann, ..., {\bf AH Wagner}, A Vogel, P Schirmacher, A Stenzinger, D Kazdal}
{British Journal of Cancer}
{2022}

\pub
{The GA4GH Phenopacket schema defines a computable representation of clinical data}
{JOB Jacobsen, ..., {\bf AH Wagner}, JL Warner, C Weiland, MA Haendel, PN Robinson}
{Nature Biotechnology}
{2022}

\pub
{A community approach to the cancer-variant-interpretation bottleneck}
{K Krysiak, ..., {\bf AH Wagner}, OL Griffith, M Griffith}
{Nature Cancer}
{2022}

\pub
{A Simple Standard for Sharing Ontological Mappings (SSSOM)}
{N Matentzoglu, ..., {\bf AH Wagner}, CJ Mungall}
{Database}
{2022}

\pub
{Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)}
{P Horak, et al.}
{Genetics in Medicine}
{2022}

\pub
{Discovery of clinically relevant fusions in pediatric cancer}
{S LaHaye, ..., {\bf Alex H Wagner}, AK Eisfeld, K Mrózek, V Magrini, CE Cottrell, ER Mardis, RK Wilson, P White}
{BMC Genomics}
{2021}

\pub
{Recommendations for future extensions to the HGNC gene fusion nomenclature}
{{\bf AH Wagner}, Y Akkari, M Li, A Roy, K Tsuchiya, G Raca}
{Leukemia}
{2021}

\pub
{GA4GH: International policies and standards for data sharing across genomic research and healthcare}
{HL Rehm, et al.}
{Cell Genomics}
{2021}

\pub
{The GA4GH Variation Representation Specification: A computational framework for variation representation and federated identification}
{{\bf AH Wagner}, L Babb, ..., RK Hart}
{Cell Genomics}
{2021}

\pub
{Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling}
{A Stenzinger, ..., {\bf AH Wagner}, F Tacke, D Capper, KR Müller, F Klauschen}
{Seminars in cancer biology}
{2021}

\pub
{Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts}
{SL Freshour*, S Kiwala*, KC Cotto*, ..., {\bf AH Wagner}}
{Nucleic Acids Research}
{2021}

\pub
{A harmonized meta-knowledgebase of clinical interpretations of somatic cancer genomic variants}
{{\bf AH Wagner}, B Walsh, G Mayfield, ..., M Griffith, OL Griffith, A Margolin}
{Nature Genetics}
{2020}

\pub
{Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices}
{S Rao, B Pitel, {\bf AH Wagner}, ..., M Griffith, OL Griffith, S Madhavan}
{JCO Clinical Cancer Informatics}
{2020}

\pub
{CIViCpy: a Python Software Development and Analysis Toolkit for the CIViC knowledgebase}
{{\bf AH Wagner}*, S Kiwala*, AC Coffman, JF McMichael, KC Cotto, TB Mooney, EK Barnell, K Krysiak, AM Danos, OL Griffith, M Griffith}
{JCO Clinical Cancer Informatics}
{2020}

\pub
{FHIR Genomics: enabling standardization for precision medicine use cases}
{G Alterovitz, B Heale, J Jones, D Kreda, F Lin, L Liu, X Liu, KD Mandl, DW Poloway, R Ramoni, {\bf AH Wagner}, JL Warner}
{npj Genom Med}
{2020}

\pub
{Standard operating procedure for curation and clinical interpretation of variants in cancer}
{AM Danos*, K Krysiak*, EK Barnell*, ..., {\bf AH Wagner}, S Madhavan, M Griffith, OL Griffith}
{Genome Med}
{2019}

\pub
{Standard operating procedure for somatic variant refinement of tumor sequencing data}
{EK Barnell, P Ronning, KM Campbell, K Krysiak, BJ Ainscough, C Ramirez, N Spies, J Kunisaki, ZL Skidmore, F Gomez, L Trani, M Matlock, {\bf AH Wagner}, SJ Swamidass, M Grififth, OL Griffith}
{Genetics in Medicine}
{2019}

\pub
{Recurrent WNT Pathway Alterations are Frequent in Relapsed Small Cell Lung Cancer}
{{\bf AH Wagner}*, S Devarakonda*, ZL Skidmore, K Krysiak, A Ramu, L Trani, J Kunisaki, ..., M Griffith, OL Griffith, R Govindan}
{Nature Communications}
{2018}

\pub
{A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data}
{BJ Ainscough*, EK Barnell*, KM Campbell, {\bf AH Wagner}, TE Rohan, R Govindan, M Griffith, ER Mardis, SJ Swamidass, OL Griffith}
{Nature Genetics}
{2018}

\pub
{Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards}
{AM Danos*, DI Ritter*, {\bf AH Wagner}, K Krysiak, ..., S Kulkarni, M Griffith, S Madhavan, OL Griffith}
{Human Mutation}
{2018}

\pub
{DGIdb 3.0: a redesign and expansion of the drug-gene interaction database}
{K Cotto*, {\bf AH Wagner}*, YY Feng, S Kiwala, AC Coffman, G Spies, A Wollam, NC Spies, OL Griffith, M Griffith }
{Nucleic Acids Research}
{2017}

\pub
{CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer}
{M Griffith, NC Spies, K Krysiak, JF McMichael, AC Coffman, AM Danos, BJ Ainscough, CA Ramirez, DT Rieke, L Kujan, EK Barnell, {\bf AH Wagner}, ..., OL Griffith}
{Nature Genetics}
{2017}

\pub
{DoCM: a database of curated mutations in cancer}
{BJ Ainscough, M Griffith, AC Coffman, {\bf AH Wagner}, J Kunisaki, MNK Choudhary, JF McMichael, RS Fulton, RK Wilson, OL Griffith, ER Mardis}
{Nature methods}
{2016}

\pub
{Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia}
{M Griffith, OL Griffith, K Krysiak, ZL Skidmore, MJ Christopher, JM Klco, A Ramu, TL Lamprecht, {\bf AH Wagner}, ..., {TJ Ley}}
{Experimental hematology}
{2016}

\pub
{GenVisR: Genomic Visualizations in R}
{ZL Skidmore, {\bf AH Wagner}, R Lesurf, KM Campbell, J Kunisaki, OL Griffith, M Griffith}
{Bioinformatics}
{2016}

\pub
{DGIdb 2.0: mining clinically relevant drug/gene interactions}
{{\bf AH Wagner}, AC Coffman, BJ Ainscough, NC Spies, ZL Skidmore, KM Campbell, K Krysiak, D Pan, JF McMichael, JM Eldred, JR Walker, RK Wilson, ER Mardis, M Griffith, OL Griffith}
{Nucleic Acids Research}
{2016}

\pub
{Transcriptomic analysis across nasal, temporal, and macular regions of human neural retina and RPE/choroid by RNA-Seq}
{SS Whitmore, {\bf AH Wagner}, AP DeLuca, AV Drack, EM Stone, BA Tucker, S Zeng, TA Braun, RF Mullins, TE Scheetz}
{Experimental Eye Research}
{2014}

\pub
{Optic nerve crush induces spatial and temporal gene expression patterns in retina and optic nerve of BALB/cJ mice}
{TP Sharma, CM McDowell, Y Liu, {\bf AH Wagner}, D Thole, BP Faga, RJ Workinger, TA Braun, AF Clark}
{Molecular Neurodegeneration}
{2014}

\pub
{Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease}
{TA Braun, RF Mullins, {\bf AH Wagner}, J Andorf, R Johnston, B Bakall, AP DeLuca, G Fisherman, R Weleber, A Cideciyan, S Jacobson, V Sheffield, B Tucker, EM Stone}
{Human Molecular Genetics}
{2013}

\pub
{Prioritization of Retinal Disease Genes: An Integrative Approach}
{{\bf AH Wagner}, KR Taylor, AP DeLuca, TL Casavant, RF Mullins, EM Stone, TE Scheetz, TA Braun}
{Human Mutation}
{2013}

\pub
{Exon-level expression profiling of ocular tissues}
{{\bf AH Wagner}, VN Anand, W Wang, JE Chatterton, D Sun, AR Shepard, N Jacobson, L Pang, AP DeLuca, TL Casavant, TE Scheetz, RF Mullins, TA Braun, AF Clark}
{Experimental Eye Research}
{2013}

\pub
{Sequencing and disease variation detection tools and techniques}
{AP DeLuca, {\bf AH Wagner}, KR Taylor, B Faga, D Thole, VC Sheffield, ..., TA Braun}
{IEEE/ACS International Conference on Computer Systems and Applications (AICCSA)}
{2011}

